STERIS plc
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automate…
What to know about STE
STERIS plc is a large Healthcare company with a mixed financial profile. It scores well on health and sentiment, but size is worth keeping an eye on.
Should you consider STE?
Based on 31 financial metrics and sector comparison. Not financial advice.
-
STERIS plc is a large-cap Healthcare company with a mixed overall financial profile — it sits in the upper half of Healthcare stocks (26 of 59).
-
Profitability is roughly average for the S&P 500 — not a standout in either direction.
-
Valuation is in the middle of the pack — neither obviously cheap nor stretched.
-
The company is growing at a reasonable pace — not the fastest, but consistently moving in the right direction.
-
There is a small dividend (0.01%), but income-focused investors will likely find better yields elsewhere in the market.
-
Volatility is close to the S&P 500 average — typical market swings, nothing unusual.
-
Analyst sentiment is broadly positive and short interest is low — professionals who cover this stock are mostly optimistic about its near-term prospects.
-
This is a mixed picture — real strengths in some areas, but areas that need watching too. Do your homework on the sector before deciding.
At a glance
How it scores
We look at 31 different financial metrics and group them into categories. Here's how STE compares to the other S&P 500 stocks.
Dive deeper — all 31 metrics 9 categories · valuation, growth, health, dividends & more Show all Hide
Valuation
Is the stock cheap or expensive relative to its earnings, sales, and assets? Lower multiples often mean better value.
| Metric | Value | vs S&P 500 |
|---|---|---|
| P/E Ratio (Trailing) | 25.55 | Average |
| Forward P/E | 16.74 | Above avg |
| PEG Ratio | 1.40 | Above avg |
| Price to Sales | 3.33 | Average |
| Price to Book | 2.76 | Above avg |
| EV/EBITDA | 13.65 | Above avg |
| Earnings Yield | 3.91% | Average |
Profitability
How efficiently does the company turn revenue into profit? Higher margins mean more money kept from each dollar earned.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Gross Margin | 44.24% | Above avg |
| Operating Margin | 20.04% | Above avg |
| Net Profit Margin | 13.18% | Above avg |
| Return on Equity | 11.37% | Average |
| Return on Invested Capital | 6.65% | Above avg |
Growth
How fast is the business expanding? Strong growth in revenue and earnings signals increasing market demand.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Revenue Growth (YoY) | 7.30% | Average |
| Revenue Growth (3Y CAGR) | 9.38% | Above avg |
| EPS Growth (YoY) | 52.20% | Top 25% |
| Free Cash Flow Growth | 24.99% | Above avg |
Health
Can the company cover its debts and obligations? A healthy balance sheet reduces the risk of financial trouble.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Current Ratio | 2.09 | Top 25% |
| Debt to Equity | 0.29 | Top 25% |
| Interest Coverage | 18.25 | Top 25% |
| Altman Z-Score | 4.77 | Above avg |
Dividends
Does the company pay shareholders, and is that payment growing and sustainable?
| Metric | Value | vs S&P 500 |
|---|---|---|
| Dividend Yield | 1.22% | Average |
| Payout Ratio | 31.02% | Above avg |
| Dividend Growth (5Y) | -5.36% | Above avg |
Cash Flow
Is real cash flowing into the business — not just accounting profits? Strong cash flow funds growth and dividends.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Free Cash Flow Yield | 4.92% | Above avg |
| OCF to Sales | 22.60% | Above avg |
Risk
How volatile is the stock compared to the broader market? Lower beta and volatility mean a smoother ride.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Beta (1-Year) | 0.92 | Above avg |
| Volatility (30-Day) | 26.36% | Above avg |
Sentiment
What do analysts and short-sellers think? High analyst ratings and low short interest signal broad confidence.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Short % of Float | 2.11% | Top 25% |
| Avg. Analyst Rating | 1.88 | Above avg |
| Target Upside % | 26.77% | Top 25% |
Size
How large is the company by market value? Size affects stability, growth potential, and index inclusion.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Market Capitalization | 19.75B | Below avg |
How does STE compare to…?
Pick another stock and see them side by side in seconds.
You might also look at
Companies in a similar position to STE — based on their financial profile.